Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Jul;18(1):167–170. doi: 10.1128/aac.18.1.167

Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.

G L Simon, D R Snydman, F P Tally, S L Gorbach
PMCID: PMC283958  PMID: 6448020

Abstract

A total of 20 serious infections were treated with piperacillin. These infections included bacteremias (5), pneumonias (5), urinary tract infections (5), soft tissue infections (3), septic arthritis (1), and osteomyelitis (1). The most common bacterial pathogen was Pseudomonas aeruginosa, accounting for eight infections. The clinical and bacteriological response rates were 75 and 70%, respectively. Four of the five patients who failed to respond to piperacillin therapy were infected with Pseudomonas. In two patients with Pseudomonas infections clinical relapse was accompanied by the development of piperacillin-resistant P. aeruginosa. The findings suggest that the use of piperacillin as a single agent for the treatment of serious gram-negative infections may be ill-advised, especially if P. aeruginosa is the offending pathogen.

Full text

PDF
167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Le Blanc B. Piperacillin: in vitro evaluation. Antimicrob Agents Chemother. 1978 Jul;14(1):78–87. doi: 10.1128/aac.14.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Curreri P. W., Lindberg R. B., DiVincenti F. C., Pruitt B. A., Jr Intravenous administration of carbenicillin for septicemia due to Pseudomonas aeruginosa following thermal injury. J Infect Dis. 1970 Sep;122(Suppl):S40–S47. doi: 10.1093/infdis/122.supplement_1.s40. [DOI] [PubMed] [Google Scholar]
  3. Darrell J. H., Waterworth P. M. Carbenicillin resistance in Pseudomonas aeruginosa from clinical material. Br Med J. 1969 Jul 19;3(5663):141–143. doi: 10.1136/bmj.3.5663.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dickinson G. M., Cleary T. J., Hoffman T. A. Comparative evaluation of piperacillin in vitro. Antimicrob Agents Chemother. 1978 Dec;14(6):919–921. doi: 10.1128/aac.14.6.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ervin F. R., Bullock W. E. Clinical and pharmacological studies of ticarcillin in gram-negative infections. Antimicrob Agents Chemother. 1976 Jan;9(1):94–101. doi: 10.1128/aac.9.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hoffman T. A., Bullock W. E. Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections. Ann Intern Med. 1970 Aug;73(2):165–171. doi: 10.7326/0003-4819-73-2-165. [DOI] [PubMed] [Google Scholar]
  7. Jones R. N., Thornsberry C., Barry A. L., Fuchs P. C., Gavan T. L., Gerlach E. H. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin. J Antibiot (Tokyo) 1977 Dec;30(12):1107–1114. doi: 10.7164/antibiotics.30.1107. [DOI] [PubMed] [Google Scholar]
  8. Lowbury E. J., Lilly H. A., Kidson A., Ayliffe G. A., Jones R. J. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet. 1969 Aug 30;2(7618):448–452. doi: 10.1016/s0140-6736(69)90163-9. [DOI] [PubMed] [Google Scholar]
  9. Lyons R. W., Thornton G. F., Andriole V. T. Carbenicillin: clinical and laboratory studies. J Infect Dis. 1970 Sep;122(Suppl):S104+–S104+. doi: 10.1093/infdis/122.supplement_1.s104. [DOI] [PubMed] [Google Scholar]
  10. Marks M. I., Eickhoff T. C. Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med. 1970 Aug;73(2):179–187. doi: 10.7326/0003-4819-73-2-179. [DOI] [PubMed] [Google Scholar]
  11. Smith C. B., Wilfert J. N., Dans P. E., Kurrus T. A., Finland M. In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin. J Infect Dis. 1970 Sep;122(Suppl):S14–S28. doi: 10.1093/infdis/122.supplement_1.s14. [DOI] [PubMed] [Google Scholar]
  12. Wise R., Andrews J. M., Bedford K. A. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs. Antimicrob Agents Chemother. 1978 Oct;14(4):549–552. doi: 10.1128/aac.14.4.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wolff S. M., Bennett J. V. Editorial: Gram-negative-rod bacteremia. N Engl J Med. 1974 Oct 3;291(14):733–734. doi: 10.1056/NEJM197410032911411. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES